Skip to content
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Press Release
Access our official statements and corporate announcements directly from the source
May 7, 2024
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Pyridam Farma for Commercialization of BINOSTO® in Indonesia
February 6, 2024
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Lupin for Commercialization of BINOSTO® in Vietnam & Philippines
September 29, 2023
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO® In The United States
May 29, 2023
|
Press Releases
Abiogen Pharma Completes the Acquisition of EffRx
July 20, 2022
|
Press Releases
EffRx Pharmaceuticals announces the launch of Alkindi® as replacement therapy for pediatric adrenal insufficiency in Switzerland
July 20, 2022
|
Press Releases
World Orphan Drug Alliance – combining forces to reach patients with rare diseases across the globe
April 26, 2022
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Efmody® in Switzerland
